MetaCap

Cytosorbents (CTSO) vs SANUWAVE Health (SNWV)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cytosorbents (CTSO) has outperformed SANUWAVE Health (SNWV) over the past year, losing 70.6% versus a loss of 95.5%. Cytosorbents is the larger company by market cap ($13.1 million vs $12.9 million), about 1.0 times the size, while SANUWAVE Health is growing revenue faster (+35.0% vs +4.1%). SANUWAVE Health converts more of its revenue into profit, with a net margin of 26.8% versus -22.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CTSO-70.58%SNWV-95.48%
+24%-39%-101%
Nov 21, 20251 yearNov 20, 2026
CTSO-80.92%SNWV-88.48%
+262%+79%-105%
Oct 14, 20245 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CTSO versus SNWV key metrics
MetricCTSOSNWV
Share price$4.16$1.50
Market cap$13.12M$12.90M
1-day change-18.91%-5.66%
YTD return-67.45%-94.97%
1-year return-70.58%-95.48%
5-year return-95.62%—
EPS (TTM)$-5.62$-0.38
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$37.06M$44.05M
Revenue growth (YoY)+4.12%+34.98%
Net income (latest FY)$-8.20M$11.81M
Gross margin71.48%77.11%
Operating margin-39.79%11.23%
Net margin-22.12%26.82%
52-week high$17.00$35.29
52-week low$2.84$1.48
Distance from 52-week high-75.53%-95.75%
Analyst consensusnone—
Avg. price target upside+1041.83%—
Average volume37.34K78.45K
Shares outstanding3.15M8.60M
Employees12955
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CTSO has outperformed SNWV by 24.9 percentage points over the past year.
  • SANUWAVE Health is more profitable, keeping 26.8 cents of every revenue dollar as net income versus -22.1 cents for Cytosorbents.
  • SANUWAVE Health grew revenue faster in its latest fiscal year (+34.98% vs +4.12%).

About Cytosorbents

CTSO stock →

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses, bilirubin in liver failure, myoglobin in trauma and critical illnesses, and inflammatory mediators and blood thinners in cardiac surgery applications, as well as to remove antithrombotic drugs and inflammatory mediators in cardiothoracic surgery applications.

Health Care · Medical/Dental Instruments · 129 employees

About SANUWAVE Health

SNWV stock →

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally.

Health Care · Medical/Dental Instruments · 55 employees

CTSO vs SNWV FAQ

Which is bigger, Cytosorbents or SANUWAVE Health?

Cytosorbents (CTSO) is larger, with a market capitalization of $13.12M compared with $12.90M for SANUWAVE Health (SNWV).

Which stock has performed better over the past year, CTSO or SNWV?

CTSO returned -70.58% over the past 12 months, compared with -95.48% for SNWV (price return, excluding dividends). Past performance does not predict future results.

Are Cytosorbents and SANUWAVE Health in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons